Use of WhatsApp for Communication Between Consulting Physicians and the Emergency Physicians

NCT ID: NCT02605317

Last Updated: 2016-01-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-01-31

Study Completion Date

2015-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to determinate outcomes of WhatsApp Messenger (a messaging program for smart phones) usage for Communication Between Consulting Physicians and the Emergency Physicians.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Effective communication between consulting physicians and the emergency physicians is critical for patients in the emergency department. WhatsApp Messenger (a messaging program for smart phones), is the most commonly used for communication in at present. WhatsApp Messenger is the most globally popular messaging application. Also, it has been started to be used for communication in healthcare. The aim of this study is to determinate outcomes of WhatsApp Messenger usage for communication between consulting and the emergency physicians.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Consultation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

WhatsApp

Consultations used WhatsApp Messenger

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

A smart phone application

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age≥18 years

Exclusion Criteria

* Patients who were not known the reason of admission to Emergency Service
* Patients who were not determined consulting Physicians' arrival duration to emergency department
* Patients who were not known the outcomes of consultation
* Patients transferred other hospitals from Emergency Service
* Patients who were not determined the time of consultation call
Minimum Eligible Age

19 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Adiyaman University Research Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Umut Gulacti

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Umut Gulacti

Role: PRINCIPAL_INVESTIGATOR

Adiyaman University of Medical Faculty

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Adiyaman University Research Hospital

Adıyaman, Central, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

References

Explore related publications, articles, or registry entries linked to this study.

Astarcioglu MA, Sen T, Kilit C, Durmus HI, Gozubuyuk G, Kalcik M, Karakoyun S, Yesin M, Zencirkiran Agus H, Amasyali B. Time-to-reperfusion in STEMI undergoing interhospital transfer using smartphone and WhatsApp messenger. Am J Emerg Med. 2015 Oct;33(10):1382-4. doi: 10.1016/j.ajem.2015.07.029. Epub 2015 Jul 31.

Reference Type BACKGROUND
PMID: 26299691 (View on PubMed)

Montag C, Blaszkiewicz K, Sariyska R, Lachmann B, Andone I, Trendafilov B, Eibes M, Markowetz A. Smartphone usage in the 21st century: who is active on WhatsApp? BMC Res Notes. 2015 Aug 4;8:331. doi: 10.1186/s13104-015-1280-z.

Reference Type BACKGROUND
PMID: 26238512 (View on PubMed)

Veneroni L, Ferrari A, Acerra S, Massimino M, Clerici CA. [Considerations on the use of WhatsApp in physician-patient communication and relationship]. Recenti Prog Med. 2015 Jul;106(7):331-6. doi: 10.1701/1940.21090. Italian.

Reference Type BACKGROUND
PMID: 26228724 (View on PubMed)

Drake TM, Claireaux HA, Khatri C, Chapman SJ. WhatsApp with patient data transmitted via instant messaging? Am J Surg. 2016 Jan;211(1):300-1. doi: 10.1016/j.amjsurg.2015.04.004. Epub 2015 May 28. No abstract available.

Reference Type BACKGROUND
PMID: 26092444 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ADYU

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Serious Game Simulation and Comics in School Students
NCT06279702 ACTIVE_NOT_RECRUITING NA